Submitted by Anonymous (not verified) on 1 December 2025 - 13:45
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 14, Status: Authorised